Literature DB >> 9156796

Partial hepatectomy reduces the endotoxin-induced peak circulating level of tumor necrosis factor in rats.

N H Kumins1, J Hunt, R L Gamelli, J P Filkins.   

Abstract

The pro-inflammatory cytokine tumor necrosis factor (TNF) is dramatically and transiently elevated in the circulation during endotoxic and septic shock and is a primary mediator in the pathogenesis of the sepsis syndrome. TNF peaks in the circulation 90 min after endotoxin administration with little variation, even among species. The specific cells, tissues, or organs that produce the high circulating level of TNF in septic shock remain unknown. The most likely sources are macrophage-laden tissues such as the liver and the spleen and circulating blood leukocytes. This study evaluated whether the liver is an important source producing the TNF spike 90 min after endotoxin. To test this hypothesis, we measured the peak circulating level of TNF following an endotoxin injection in rats subjected to a two-thirds hepatectomy versus sham-operated controls. Hepatechectomized rats produced 64% less TNF after endotoxin than controls (857 + or - 143 pg/mL plasma vs. 2410 + or - 491, respectively; p < .01). In contrast, splenectomy did not significantly after peak TNF levels versus sham-operated controls following an endotoxin injection (1380 + or - 148 pg/mL plasma vs. 1710 + or - 291). Furthermore, incubation of rat blood with endotoxin for 90 min did not significantly increase TNF above controls. These experiments demonstrate an important role for the liver in producing the high circulating levels of TNF after an endotoxin injection and suggest that hepatic-specific cytokine modulation deserves study for a therapeutic benefit in septic shock.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9156796     DOI: 10.1097/00024382-199605000-00012

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.

Authors:  Liya Qin; Xuefei Wu; Michelle L Block; Yuxin Liu; George R Breese; Jau-Shyong Hong; Darin J Knapp; Fulton T Crews
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

2.  Redox imbalance differentially inhibits lipopolysaccharide-induced macrophage activation in the mouse liver.

Authors:  F Wang; L Y Wang; D Wright; M J Parmely
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival.

Authors:  Damiano Conte; Martin Holcik; Charles A Lefebvre; Eric Lacasse; David J Picketts; Kathryn E Wright; Robert G Korneluk
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

4.  An insight into the possible protective effect of pyrrolidine dithiocarbamate against lipopolysaccharide-induced oxidative stress and acute hepatic injury in rats.

Authors:  Hanan H Hagar
Journal:  Saudi Pharm J       Date:  2009-11-10       Impact factor: 4.330

5.  Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.

Authors:  C R Amura; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease.

Authors:  Pragna Rao; G C Reddy; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  2008-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.